Enigma of HIV-1 latent infection in astrocytes: An in-vitro study using protein kinase C agonist as a latency reversing agent

Microbes and Infection

Volumn 17, Issue 9, 2015, Pages 651-659

  Chauhan, Ashok ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chloroquine; DDX3; HIV 1 brain; HIV 1 latency; Phorbol 12 myristate 13 acetate; TRBP

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; TRANSACTIVATOR PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PHORBOL ESTER; PHORBOL-12-MYRISTATE; PROTEIN KINASE C;

ARTICLE; ASTROCYTE; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; FETUS; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; PRIORITY JOURNAL; REVERSE GENETICS; VIRUS LATENCY; VIRUS RELEASE; VIRUS REPLICATION; BRAIN; CELL CULTURE; CELL LINE; CYTOLOGY; HEK293 CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; VESICULAR STOMATITIS VIRUS;

ANTI-HIV AGENTS; ASTROCYTES; BRAIN; CELL LINE; CELLS, CULTURED; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; PHORBOL ESTERS; PROTEIN KINASE C; VIRUS LATENCY;

EID: 84940448298     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2015.05.006     Document Type: Article

References (50)

1. Sacktor N., McDermott M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002, 8:136-142.
2. Chan P., Brew B.J. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Curr HIV/AIDS Rep 2014, 11:317-324.
3. Spudich S.S. CROI 2014: neurologic complications of HIV infection. Top Antivir Med 2014, 22:594-601.
4. Xing H.Q., Hayakawa H., Izumo K., Kubsota R., Gelpi E., Budka H., et al. In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathology 2009, 29:433-442.
5. Mehla R., Bivalkar-Mehla S., Nagarkatti M., Chauhan A. Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator. J Neuroinflammation 2012, 9:239.
6. Siliciano R.F. Opening fronts in HIV vaccine development: targeting reservoirs to clear and cure. Nat Med 2014, 20:480-481.
7. Deeks S.G. HIV: shock and kill. Nature 2012, 487:439-440.
8. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999, 13:1-22.
9. Barouch D.H., Deeks S.G. Immunologic strategies for HIV-1 remission and eradication. Science 2014, 345:169-174.
10. Stevenson M. CROI: basic science review. Top Antivir Med 2014, 22:574-578.
11. Speck R.F., Esser U., Penn M.L., Eckstein D.A., Pulliam L., Chan S.Y., et al. A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Curr Biol 1999, 9:547-550.
12. Chauhan A., Mehla R., Theophilus-Sunder V.K., Handy I. Endocytosis-mediated HIV-1 entry and its significance in the elusive behavior of the HIV-1 in astrocytes. Virology 2014, 456-457:1-19.
13. Sharpless N., Gilbert D., Vandercam B., Zhou J.M., Verdin E., Ronnett G., et al. The restricted nature of HIV-1 tropism for cultured neural cells. Virology 1992, 191:813-825.
14. Clarke J.N., Lake J.A., Burrell C.J., Wesselingh S.L., Gorry P.R., Li P. Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes. Virology 2006, 348:141-155.
15. Dewhurst S., Sakai K., Bresser J., Stevenson M., Evinger-Hodges M.J., Volsky D.J. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol 1987, 61:3774-3782.
16. An S.F., Groves M., Giometto B., Beckett A.A., Scaravilli F. Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol 1999, 98:481-487.
17. An S.F., Groves M., Gray F., Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 1999, 58:1156-1162.
18. Trillo-Pazos G., Diamanturos A., Rislove L., Menza T., Chao W., Belem P., et al. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003, 13:144-154.
19. Churchill M.J., Gorry P.R., Cowley D., Lal L., Sonza S., Purcell D.F., et al. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol 2006, 12:146-152.
20. Churchill M.J., Wesselingh S.L., Cowley D., Pardo C.A., McArthur J.C., Brew B.J., et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 2009, 66:253-258.
21. Desplats P., Dumaop W., Smith D., Adame A., Everall I., Letendre S., et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 2013, 80:1415-1423.
22. Lambotte O., Deiva K., Tardieu M. HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol 2013, 13:95-103.
23. Smith D.B., Simmonds P., Bell J.E. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users. J Neurovirol 2014, 20:28-38.
24. Tavazzi E., Morrison D., Sullivan P., Morgello S., Fischer T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr HIV Res 2014, 12:97-110.
25. Nath A., Hartloper V., Furer M., Fowke K.R. Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 1995, 54:320-330.
26. Li J., Bentsman G., Potash M.J., Volsky D.J. Human immunodeficiency virus type 1 efficiently binds to human fetal astrocytes and induces neuroinflammatory responses independent of infection. BMC Neurosci 2007, 12(8):31.
27. Vijaykumar T.S., Nath A., Chauhan A. Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection. Virology 2008, 381:1-5.
28. Chauhan A. Unperturbed posttranscriptional regulatory Rev protein function and HIV-1 replication in astrocytes. PLoS One 2014, 9:e106910.
29. Chiodi F., Fuerstenberg S., Gidlund M., Asjo B., Fenyo E.M. Infection of brain-derived cells with the human immunodeficiency virus. J Virol 1987, 61:1244-1247.
30. Tornatore C., Nath A., Amemiya K., Major E.O. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 1991, 65:6094-6100.
31. Atwood W.J., Tornatore C.S., Traub R., Conant K., Drew P.D., Major E.O. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. AIDS Res Hum Retroviruses 1994, 10:1207-1211.
32. Lawrence D.M., Durham L.C., Schwartz L., Seth P., Maric D., Major E.O. Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol 2004, 78:7319-7328.
33. Narasipura S.D., Kim S., Al-Harthi L. Epigenetic regulation of HIV-1 latency in astrocytes. J Virol 2014, 88:3031-3038.
34. Narasipura S.D., Henderson L.J., Fu S.W., Chen L., Kashanchi F., Al-Harthi L. Role of,β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol 2012, 86:1911-1921.
35. Chauhan A., Hahn S., Gartner S., Pardo C.A., Netesan S.K., McArthur J., et al. Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. FASEB J 2007, 21:777-789.
36. Kutsch O., Benveniste E.N., Shaw G.M., Levy D.N. Direct and quantitative single cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 2002, 76:8776-8786.
37. Yedavalli V.S., Neuveut C., Chi Y.H., Kleiman L., Jeang K.T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119:381-392.
38. Zhang R., Mehla R., Chauhan A. Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus -1 preintegration complex (DNA). PLoS One 2010, 5:e15620.
39. Mehla R., Bivalkar-Mehla S., Zhang R., Handy I., Albrecht H., Giri S., et al. Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner. PloS One 2010, 5:e11160.
40. Bullen C.K., Laird G.M., Durand C.M., Siliciano J.D., Siliciano R.F. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat Med 2014, 20:425-429.
41. Gorry P.R., Howard J.L., Churchill M.J., Anderson J.L., Cunningham A., Adrian D., et al. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev. J Virol 1999, 73:352-361.
42. Neumann M., Afonina E., Ceccherini-Silberstein F., Schlicht S., Erfle V., Pavlakis G.N., et al. Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein. J Cell Sci 2001, 114:1717-1729.
43. Fang J., Acheampong E., Dave R., Wang F., Mukhtar M., Pomerantz R.J. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes. Virology 2005, 336:299-307.
44. Canki M., Thai J.N., Chao W., Ghorpade A., Potash M.J., Volsky D.J. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol 2001, 75:7925-7933.
45. Marban C., Suzanne S., Dequiedt F., de Walque S., Redel L., Van Lint C., et al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 2007, 26:412-423.
46. Marban C., Redel L., Suzanne S., Van Lint C., Lecestre D., Chasserot-Golaz S., et al. COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells. Nucleic Acids Res 2005, 33:2318-2331.
47. Upla P., Marjomäki V., Kankaanpää P., Ivaska J., Hyypiä T., Van Der Goot F.G., et al. Clustering induces a lateral redistribution of alpha 2 beta 1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization. Mol Biol Cell 2004, 15:625-636.
48. Constantinescu S.N., Cernescu C.D., Popescu L.M. Effects of protein kinase C inhibitors on viral entry and infectivity. FEBS Lett 1992, 292:31-33.
49. Rothenaigner I., Kramer S., Ziegler M., Wolff H., Kleinschmidt A., Brack-Werner R. Long-term HIV-1 infection of neural progenitor populations. AIDS 2007, 21:2271-2281.
50. Bencheikh M., Bentsman G., Sarkissian N., Canki M., Volsky D.J. Replication of different clones of human immunodeficiency virus type 1 in primary fetal human astrocytes: enhancement of viral gene expression by Nef. J Neurovirol 1999, 5:115-124.